Fresh skinny jab warning over links to deadly cancer diagnosis
American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common diabetes drugs.
NBC214h
Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
Hosted on MSN16h
No Link Seen Between GLP-1 Receptor Agonist Use and Thyroid Cancer
Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an increased risk for thyroid cancer over the ...
Healio21h
Top in endocrinology: New criteria for diagnosing obesity; Medicare price negotiations
A report from The Lancet Diabetes & Endocrinology Commission has proposed new criteria for defining and diagnosing obesity, ...
Not just weight loss, GLP-1 drugs like Ozempic can help with 175 conditions; says groundbreaking study
A discovery reveals that weight loss drugs like Ozempic and Mounjaro can positively impact 175 diseases and conditions beyond ...
ndtvprofit5d
Don't Pin All Your Hopes On Weight Loss Drugs: Here's Why
Besides diabetes, obesity is a major risk factor for hypertension and heart disease, creating what can only be described as a ...
Mounjaro vs. Ozempic: Which One Is Best for Me to Try for Weight Loss in 2025?
In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...
Innovent Presents at the 43rd Annual J.P. Morgan Healthcare Conference
During the conference, Dr. De-Chao Michael Yu, Founder, Chairman and CEO of Innovent, delivered a presentation highlighting 2025 as a pivotal year for significantly business growth and concreate steps ...